Scarica l'app Stockscreener
1.75
1.74%
0.03
Precedente Chiudi:
$1.72
Aprire:
$1.72
Volume 24 ore:
65,738
Relative Volume:
0.59
Capitalizzazione di mercato:
$82.44M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.57%
1M Prestazione:
-12.06%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.6699
$1.84
Intervallo di 1 settimana:
$1.6699
$1.84
Portata 52W:
$1.39
$2.20
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Nome
Whitehawk Therapeutics Inc
Settore
Industria
Telefono
551-321-2234
Indirizzo
2 HEADQUARTERS PLAZA, MORRISTOWN
Confronta WHWK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
1.75 | 84.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-08-21 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-21 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-01-11 | Iniziato | Jefferies | Buy |
| 2021-10-01 | Iniziato | Cowen | Outperform |
| 2021-09-14 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-09-08 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Whitehawk Therapeutics Inc Borsa (WHWK) Ultime notizie
How to track smart money flows in Whitehawk Therapeutics Inc.Asset Growth Pattern and Return Summary - Newser
Detecting support and resistance levels for Whitehawk Therapeutics Inc.Real Time Stock Movement and Alerts - Newser
Whitehawk Therapeutics Inc. stock daily chart insightsFree Triple Digit Return Stock Predictions - Newser
Whitehawk Therapeutics (NASDAQ:WHWK) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Has Whitehawk Therapeutics Inc. found a price floorFree Growth Focused Entry Plan Suggestions - Newser
Whitehawk Therapeutics Inc. stock volume spike explainedTrade Ideas Based on Fundamental Metrics - Newser
How Whitehawk Therapeutics Inc. stock performs during market volatilityReversal Pattern Insights with Entry Tips - Newser
What institutional flow reveals about Whitehawk Therapeutics Inc.Momentum Prediction Based on AI Backtesting - Newser
What momentum shifts mean for Whitehawk Therapeutics Inc.ROI Focused Watchlist with Trade Confidence - Newser
What makes Whitehawk Therapeutics Inc. stock price move sharplyLow Drawdown Picks with Weekly Updates - Newser
Published on: 2025-08-09 02:18:04 - Newser
Whitehawk Therapeutics (NASDAQ:WHWK) Downgraded to “Strong Sell” Rating by Wall Street Zen - Defense World
Heatmap analysis for Whitehawk Therapeutics Inc. and competitorsShort-Term Profit Alert With Entry Forecast - Newser
Full technical analysis of Whitehawk Therapeutics Inc. stockSwing Candidate List with Trade Cues - Newser
What earnings revisions data tells us about Whitehawk Therapeutics Inc.Technical Long-Term Outlook and Recap Guide - Newser
Whitehawk Therapeutics Advances ADC Portfolio Amid Financial Growth - TipRanks
Technical analysis overview for Whitehawk Therapeutics Inc. stockFree Swing Setup With Technical Confirmation - Newser
Whitehawk Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Whitehawk Therapeutics earnings missed by $1.01, revenue was in line with estimates - Investing.com Canada
Whitehawk Therapeutics Reports Q2 GAAP EPS of -$0.76, Cash Reserves Reach $177.2 Million - AInvest
Whitehawk Therapeutics Triples Cash Reserves to $177M, Fast-Tracks Three Cancer Drug Programs - Stock Titan
Pattern recognition hints at Whitehawk Therapeutics Inc. upsideMomentum-Based Prediction for Quick Returns - Newser
Forecasting Whitehawk Therapeutics Inc. price range with options dataInsider Strategy for High Conviction Picks - Newser
Developing predictive dashboards with Whitehawk Therapeutics Inc. dataShort-Term Price Breakout Signal Analysis - Newser
Using RSI to spot recovery in Whitehawk Therapeutics Inc.Breakout Monitoring with Momentum Analysis - Newser
What MACD and RSI say about Whitehawk Therapeutics Inc.Pattern Breakout Prediction for Short Term - Newser
What are the latest earnings results for Whitehawk Therapeutics Inc.Unlock your trading potential with expert tips - Jammu Links News
How strong is Whitehawk Therapeutics Inc. company’s balance sheetGet alerts on the hottest stocks daily - Jammu Links News
What analysts say about Whitehawk Therapeutics Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is Whitehawk Therapeutics Inc. a good long term investmentUnlock exclusive trading strategies for gains - Jammu Links News
What institutional investors are buying Whitehawk Therapeutics Inc. stockUnlock powerful trading signals for profits - Jammu Links News
Price action breakdown for Whitehawk Therapeutics Inc.Long Hold Investment Strategy with Growth Focus - Newser
Backtesting results for Whitehawk Therapeutics Inc. trading strategiesReal-Time Investment Signal Forecast with AI - Newser
Should I hold or sell Whitehawk Therapeutics Inc. stock in 2025Invest smarter with data-backed insights - Jammu Links News
Why is Whitehawk Therapeutics Inc. stock attracting strong analyst attentionDiscover high-impact investment opportunities - Jammu Links News
How does Whitehawk Therapeutics Inc. generate profit in a changing economyAchieve consistent double-digit growth rates - Jammu Links News
Is Whitehawk Therapeutics Inc. a growth stock or a value stockMaximize returns with smart investment plans - Jammu Links News
Whitehawk Therapeutics Inc Azioni (WHWK) Dati Finanziari
Non sono disponibili dati finanziari per Whitehawk Therapeutics Inc (WHWK). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):